Cemile Ucgul Atilgan
Overview
Explore the profile of Cemile Ucgul Atilgan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tekin K, Atilgan C
Arq Bras Oftalmol
. 2025 Feb;
88(2):e20240292.
PMID: 40008720
No abstract available.
2.
Tekin K, Inanc M, Atilgan C
Arq Bras Oftalmol
. 2025 Jan;
88(1).
PMID: 39879483
No abstract available.
3.
Kucukevcilioglu M, Yesiltas Y, Durukan A, Unlu N, Onen M, Alp M, et al.
Medicina (Kaunas)
. 2023 Feb;
59(2).
PMID: 36837465
The aim of this study was to compare the outcomes of diabetic macular edema (DME) treated with aflibercept (AFB) or ranibizumab (RNB) only, and after switching from RNB to AFB....
4.
Atilgan C, Hondur G, Citirik M
J Glaucoma
. 2022 Aug;
32(1):19-26.
PMID: 35980842
Prcis: The macular and peripapillary structural and vascular alterations in elderly patients with age-related choroidal atrophy may mimic glaucomatous degeneration. Purpose: To evaluate the peripapillary retinal nerve fiber layer (pRNFL),...
5.
Durukan A, Unlu N, Onen M, Alp M, Yesiltas Y, Kalayci D, et al.
Int Ophthalmol
. 2022 Jul;
42(12):3777-3787.
PMID: 35829865
Purpose: This study aimed to report the visual and anatomical outcomes of intravitreal anti-VEGF treatment for diabetic macular edema (DME) in a real-world clinical setting from Turkey over 36 months....
6.
Atilgan C, Yozgat A, Kosekahya P, Goker Y, Sen E, Yetkin E, et al.
Arq Bras Oftalmol
. 2022 Jun;
85(3):286-293.
PMID: 35730818
Purpose: To evaluate the radial peripapillary capillary density using optical coherence tomography angiography in patients with and without Helicobacter pylori infection. Methods: This prospective, cross-sectional study comprised 52 patients (52...
7.
Atilgan C, Goker Y, Hondur G, Kosekahya P, Kocer A, Citirik M
Ther Adv Ophthalmol
. 2022 Apr;
14:25158414221090092.
PMID: 35464343
Background: Given that unilateral branch retinal vein occlusion (BRVO) and glaucoma share common systemic vascular risk factors, the fellow eyes of patients with BRVO may be at increased risk of...
8.
Atilgan C, Kosekahya P, Yetkin E, Caglayan M, Goker Y, Sendul S
Beyoglu Eye J
. 2022 Jan;
5(2):64-72.
PMID: 35098066
Objectives: The aim of this study was to assess the effects of topical 0.1% nepafenac and 0.1% fluorometholone on macular thickness (MT) after a neodymium: yttrium-aluminum-garnet (Nd: YAG) laser posterior...
9.
Akpolat C, Sendul S, Turkoglu Unal E, Karatas E, Atilgan C, Demir M
Ther Adv Ophthalmol
. 2021 Jul;
13:25158414211030427.
PMID: 34291188
Purpose: To determine the demographic and clinical characteristics of newborn patients who underwent lacrimal probing surgical intervention with or without the marsupialization of intranasal cysts as the primary management for...
10.
Hondur G, Atilgan C, Hondur A
Int Ophthalmol
. 2021 Jul;
41(11):3805-3813.
PMID: 34272630
Purpose: This cross-sectional study compared the peripapillary vessel density and retinal nerve fiber layer (RNFL) thickness in patients with exfoliation syndrome (XFS) and healthy controls for evaluation of the early...